The Food and Drug Administration, in its first enforcement operation with the government of India, recently stopped about 500 shipments of unapproved prescription drugs and combination medical devices from reaching U.S. consumers, the agency announced today. The shipments, many sent through third-party countries to conceal their origin, included about 50 FDA-regulated products, including cancer and HIV medications and opioid products, FDA said. “Consumers and physicians purchasing medicines cannot be assured the products they are receiving are legitimate, safe or effective if they are obtained from outside of the FDA-regulated pharmaceutical supply chain,” said FDA Commissioner Stephen Hahn, M.D.  

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on lowering prescription drugs prices, which focused on the drug supply chain.…
Headline
The Food and Drug Administration Friday alerted hospitals and others to a temporary shortage of a tracheostomy tube used to help adult and pediatric patients…
Headline
The Centers for Medicare & Medicaid Services last week announced planned changes to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies…
Headline
The National Academies of Sciences, Engineering, and Medicine will host a public workshop Sept. 5-6 on “Medical Product Shortages during Disasters:…
Headline
The Association for Health Care Resource & Materials Management yesterday presented its 2018 George R. Gossett Leadership Award to Deborah Sprindzunas, who…
Headline
The Food and Drug Administration today approved a domestic system for producing Technetium-99m, the most widely used radioisotope for nuclear medical imaging.…